Centering discussion on two clinical scenarios, expert panelists review recent evolutions in the field of graft vs host disease management and provide their perspective on optimal treatment strategies.
EP. 1: GVHD in the Context of Stem Cell or Allogeneic Transplant
Expert panelists elucidate the occurrence of graft vs host disease in patients receiving either stem cell or allogeneic transplantation.
EP. 2: Armamentarium for Graft vs Host Disease Prophylaxis
Hematologist/oncologists provide a broad overview of the pharmacologic agents used to prevent graft vs host disease at their institutions.
EP. 3: Understanding the Pathophysiology of Acute vs Chronic GVHD
Shared insight on the pathophysiology of graft vs host disease, with specific regard for differences between acute GVHD vs chronic GVHD.
EP. 4: Scenario 1: A 44-Year-Old Man With Acute Graft vs Host Disease
Centering discussion on a scenario of acute graft vs host disease, expert panelists consider optimal workup of a patient showing signs of GVHD.
EP. 5: Biomarkers for the Prognostication of Graft vs Host Disease
Expert hematologist/oncologists share their perspectives on use of biomarkers to help prognosticate graft vs host disease.
EP. 6: Selecting Optimal Therapy for Acute GVHD
Focusing on pharmacologic options, expert panelists review frontline treatment strategies for patients with acute graft vs host disease.
EP. 7: Selecting Therapy for Patients With a Partial Response to Frontline Therapy
Shared insight on treatment approaches toward patients with acute graft vs host disease who experience partial response to frontline therapy.
EP. 8: Scenario 2: A 59-Year-Old Woman With Chronic GVHD
After reviewing a clinical scenario of chronic graft vs host disease, panelists consider the importance of different allogeneic transplant types.
EP. 9: Optimal Staging Strategies for Chronic Graft vs Host Disease
Expert hematologist/oncologists highlight challenges in staging chronic graft vs host disease and share strategies to optimize cGHVD assessment.
EP. 10: Treatment Armamentarium for Chronic Graft vs Host Disease
Comprehensive discussion on the pharmacologic treatment armamentarium available for patients with chronic graft vs host disease.
EP. 11: Future Directions in Graft vs Host Disease Management
Closing out their panel on GVHD management, expert hematologist/oncologists share their hope for future evolution in the treatment landscape.
EP. 12: Recap: Identifying Chronic Graft-Vs-Host Disease and Discussing Treatment Options
Centering discussion on two clinical scenarios, expert panelists review recent evolutions in the field of graft-vs-host disease management and provide their perspective on optimal treatment strategies.
2 Clarke Drive Cranbury, NJ 08512